The CDC advised adults 60+ could have a lifetime RSV vaccine dose; now, it's recommended for those 75+, plus certain conditions at 60-74, with others consulting healthcare providers for risk assessment.
CDC's updated guidelines aim to enhance effectiveness and safety of RSV vaccines based on recent data, with a personalized approach for different age groups to mitigate infection risks for vulnerable populations.
Collection
[
|
...
]